Other
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of CBR-2092 in Healthy Volunteers (CBR-2092-001)
Pharmacy Faculty Research
Role
Lead Pharmacist
Date
1-1-2006
Sponsor
Cumbre Pharmaceuticals, Inc.
Location
Dallas, TX
Disciplines
Citation Information
Jeffrey L. Huston. "A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of CBR-2092 in Healthy Volunteers (CBR-2092-001)" (2006) Available at: http://works.bepress.com/jeffrey_huston/3/